Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "warner chilcott"

Mylan launches risedronate sodium tablets 150 mg in US market

Mylan Inc. has launched risedronate sodium tablets USP, 150 mg, the generic version of Warner Chilcott's Actonel tablets. Mylan received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) ... PharmaBiz, 1 month ago
Mylan releases generic Actonel Chain Drug Review, 1 month ago

2 images for "warner chilcott"

News is my Business, 3 months ago
Fat Pitch Financials, 6 months ago

Warner Chilcott, Mayne Pharma to Settle Over Claims on Generic Doryx Delay

Brand manufacturer Mayne Pharma and the U.S. marketer of Mayne's acne drug Doryx, Warner Chilcott, have moved to settle class action claims with third party purchasers that allege the two companies inappropriately delayed generic competition on the ...
 FDA News2 days ago

Foamix Establishes U.S. Subsidiary and Strengthens Executive Management With Appointment of Senior U.S. Leadership Team

New Senior Managers and Advisors Were Previously at Warner-Chilcott Inc., Overseeing Revenue Growth from $117 Million in 2001 to More Than $2.7 Billion in 2011. Team Brings Expertise in Sales, Marketing, Operations, Clinical Development, ...
 Virtual Strategy Magazine1 month ago Salix, Cosmo See Green in $2.7B Merger  Genetic Engineering News2 weeks ago HBM Healthcare Investments : Paratek Pharmaceuticals signs merger agreement with NASDAQ-listed Transcept Pharmaceuticals  4 Traders3 weeks ago Bay Area's Transcept Pharmaceuticals, Inc. Soars On Plans To Merge With Paratek Pharmaceuticals, Inc., Picks Up $93 Million Along The Way; Stock Up +19.60% At Market Close (July 1, 2014)  BioSpace3 weeks ago

New Market Report Now Available: Warner Chilcott Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

New Consumer Goods market report from MarketLine: "" Boston, MA -- (SBWIRE) -- 06/24/2014 -- MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and ...
 Digital Journal1 month ago

69.5% Return Seen to Date on SmarTrend Warner Chilcott Call (WCRX)

(SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Warner Chilcott (NASDAQ:WCRX) on January 17th, 2013 at $13.53. In approximately 17 months, Warner Chilcott has returned 69.54% as of today's recent price of $22.93. Over ...
 TradingCharts.com1 month ago Uptrend Call Working As Warner Chilcott Stock Rises 69.5% (WCRX)  Comtex SmarTrend1 month ago

Mylan introduces generic Actonel tablets 150mg

US-based pharmaceutical firm Mylan has launched Risedronate Sodium Tablets USP, 150mg, the generic version of Warner Chilcott's Actonel Tablets. The company secured final approval from the US Food and Drug Administration (FDA) for its abbreviated ...
 Pharmaceutical Business Review1 month ago


Cadila Healthcare and Zydus Pharmaceuticals of Ahmedabad have finalised an agreement with Warner Chilcott of USA to settle patent litigation related to Asacol. As per the agreement, Zydus will get a royalty bearing licence to sell a ...
 Pharmacy Choice1 month ago
JD Supra

Editorial: Corporate Inversions No Signs Of Slowing Down

In a corporate inversion, a U.S. corporation — typically the parent of an affiliated group — becomes a wholly owned subsidiary of a foreign corporation through a merger into the foreign corporation's U.S. subsidiary or transfers its assets to ...
 JD Supra14 hours ago Corporate inversions showing no signs of slowing down  Lexology1 month ago

The Best Health Care Stock To Own Right Now

If their advisor tells them their portfolio is up say 7% this year, they'll come back with something like "Yeah, but if such-and-such investment hadn't tanked, I'd be up 10%." Because the pain of losses tends to outweigh the thrill of gains, I ...
 Yahoo! Finance17 hours ago

What The SEC Should Ask Valeant; Allergan Investors Should Watch Out

Summary Valeant complained to the SEC about Allergan's "misstatements" on B&L organic growth. The SEC should take this opportunity to examine Valeant's earnings releases and ask the following from Valeant. Clearly report the negative organic ...
 Seeking Alpha3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less